NF-κB, a transcription factor, represents a cardinal regulator of inflammation and persistent (constitutive) activation of NF-κB contributes to the development and progression of a number of cancers, including breast cancer [29,35,36]. This evidence concerns the gene NFKB1 and breast carcinoma.